{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Exicure, Inc."},"Symbol":{"label":"Symbol","value":"XCUR"},"Address":{"label":"Address","value":"2430 N. HALSTED STREET,SUITE 410, CHICAGO, Illinois, 60614, United States"},"Phone":{"label":"Phone","value":"+1 847 673-1700"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Exicure Inc is a clinical-stage biotechnology company that develops nucleic acid therapies targeting ribonucleic acid against validated targets for neurological disorders and hair loss. It operates in a single segment, which is the discovery, research, and development of treatments based on its SNA (Spherical Nucleic Acid) technology."},"CompanyUrl":{"label":"Company Url","value":"https://www.exicuretx.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Paul Kang","title":"President, Chief Executive Officer & Director"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}